statistiche ricercatore

Continente	#
AS - Asia	389
NA - Nord America	358
EU - Europa	191
SA - Sud America	71
AF - Africa	34
OC - Oceania	2
Continente sconosciuto - Info sul continente non disponibili	1
Totale	1.046

Nazione	#
US - Stati Uniti d'America	345
SG - Singapore	134
CN - Cina	93
VN - Vietnam	88
IT - Italia	65
BR - Brasile	52
HK - Hong Kong	28
DE - Germania	23
ZA - Sudafrica	20
SE - Svezia	19
FR - Francia	18
IE - Irlanda	18
IN - India	11
AR - Argentina	9
CA - Canada	9
NL - Olanda	9
GB - Regno Unito	7
ES - Italia	6
BD - Bangladesh	5
IQ - Iraq	5
RU - Federazione Russa	5
AT - Austria	4
EC - Ecuador	4
EG - Egitto	4
FI - Finlandia	4
JP - Giappone	4
PL - Polonia	4
TR - Turchia	4
TW - Taiwan	4
CI - Costa d'Avorio	3
CL - Cile	3
PH - Filippine	3
AL - Albania	2
KR - Corea	2
KZ - Kazakistan	2
MX - Messico	2
NG - Nigeria	2
TN - Tunisia	2
AU - Australia	1
AZ - Azerbaigian	1
BG - Bulgaria	1
CO - Colombia	1
CR - Costa Rica	1
CZ - Repubblica Ceca	1
DO - Repubblica Dominicana	1
HU - Ungheria	1
ID - Indonesia	1
IR - Iran	1
LT - Lituania	1
LV - Lettonia	1
LY - Libia	1
MA - Marocco	1
MY - Malesia	1
NZ - Nuova Zelanda	1
PT - Portogallo	1
PY - Paraguay	1
RO - Romania	1
SN - Senegal	1
TH - Thailandia	1
UZ - Uzbekistan	1
VE - Venezuela	1
XK - ???statistics.table.value.countryCode.XK???	1
Totale	1.046

Nome	#
The aflatox® project: Approaching the development of new generation, natural‐based compounds for the containment of the mycotoxigenic phytopathogen Aspergillus flavus and aflatoxin contamination	162
SARS-CoV-2 Infection Risk and COVID-19 Prevalence and Mortality in Cancer Patients During the First Wave of COVID-19 Pandemic in a Virus Epicenter in Northern Italy	161
Antiaflatoxigenic Thiosemicarbazones as Crop-Protective Agents: A Cytotoxic and Genotoxic Study	153
Use of FTA® classic cards for epigenetic analysis of sperm DNA	150
Genetic Basis of Breast and Ovarian Cancer: Approaches and Lessons Learnt from Three Decades of Inherited Predisposition Testing	144
Randomized, open-label, phase II, biomarker study of immune-mediated mechanism of action of neoadjuvant subcutaneous trastuzumab in patients with locally advanced, inflammatory, or early HER2-positive breast cancer-Immun-HER trial (GOIRC-01-2016)	107
Functional HRD by RAD51 identifies BRCA1 VUS associated with loss of gene function and response to DNA-damaging agents	104
Bridging bench to bedside: The evolution and impact of translational research in oncology. The experience of the Gruppo Oncologico Italiano di Ricerca Clinica (GOIRC)	85
Totale	1.066

	Totale	Lug	Ago	Sett	Ott	Nov	Dic	Gen	Feb	Mar	Apr	Mag	Giu
2020/2021	11	0	0	0	0	0	0	0	0	0	0	1	10
2021/2022	23	0	0	0	0	0	1	8	3	3	2	1	5
2022/2023	80	8	9	7	9	5	11	0	5	22	1	2	1
2023/2024	56	1	0	1	0	4	9	3	4	1	14	13	6
2024/2025	219	15	9	14	15	19	20	10	12	23	19	17	46
2025/2026	645	63	85	106	77	67	38	53	33	85	38	0	0
Totale													1.066